Australia markets open in 6 hours 16 minutes

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.3900-0.1600 (-4.51%)
At close: 04:00PM EDT
3.3000 -0.09 (-2.65%)
After hours: 05:48PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts18181818
Avg. Estimate-0.43-0.44-1.69-1.68
Low estimate-0.66-0.65-2.62-2.11
High estimate-0.37-0.36-1.21-0.85
Year ago EPS-0.46-0.45-1.64-1.69
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts16151716
Avg. Estimate1.32M1.12M11.28M3.64M
Low estimateN/AN/A8.7MN/A
High estimate5M6.3M20M20M
Year ago sales1.94M1.68M65.53M11.28M
Sales growth (year/est)-32.10%-33.20%-82.80%-67.70%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.57-0.52-0.49-0.47
Actual EPS-0.46-0.45-0.47-0.33
Difference0.110.070.020.14
Surprise %19.30%13.50%4.10%29.80%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.43-0.44-1.69-1.68
7 days ago-0.43-0.44-1.7-1.67
30 days ago-0.48-0.48-1.9-1.85
60 days ago-0.48-0.48-1.9-1.85
90 days ago-0.48-0.48-1.9-1.85
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days15151616
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFATEIndustrySector(s)S&P 500
Current qtr.6.50%N/AN/AN/A
Next qtr.2.20%N/AN/AN/A
Current year-3.00%N/AN/AN/A
Next year0.60%N/AN/AN/A
Next 5 years (per annum)-37.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A